Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

SmartDyeLivery

SmartDyeLivery
2014 FOUNDED
PRIVATE STATUS
PE Growth LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Developer of nanoparticulate drug delivery systems based on a comprehensively patented platform technology intended for cell-type-specific treatment of impaired cellular signal functions. The company's platform technology also allows for system- or organ-specific modification of central effector functions of specific cells while reducing or avoiding unwanted side effects.

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Drug Discovery
Primary Office
  • Botzstrasse 5
  • 07743 Jena
  • Germany

+49 03641 000000

SmartDyeLivery Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore SmartDyeLivery‘s full profile, request access.

Request full access to PitchBook

SmartDyeLivery Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore SmartDyeLivery‘s full profile, request access.

Request full access to PitchBook

SmartDyeLivery Executive Team (2)

Name Title Board
Seat
Contact
Info
Georg Hochwimmer Ph.D Co-Chief Executive Officer & Managing Director
Marc Lehmann Co-Chief Executive Officer & Managing Director